Abstract
Michael Jordan returned from retirement to lead the Chicago Bulls to three straight NBA championships, and researchers hope that a chemical can pull off a similarly splashy comeback and challenge Alzheimer's disease. The first clinical trials of the drug, an antibiotic that was retired more than 30 years ago, suggest that it slows progression of the illness in the most severely affected patients. The work also supports the hypothesis that jumbled metal metabolism in the older brain promotes deterioration.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
